Gene expression profiling of mucolipidosis type IV fibroblasts reveals deregulation of genes with relevant functions in lysosome physiology

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 4, 2008, Pages 250-258

  Bozzato, Andrea ^a   Barlati, Sergio ^a   Borsani, Giuseppe ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Gene expression profiling; Gene ontology; Lysosomal diseases; Microarray; Mucolipidosis type IV

Indexed keywords

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LYSOSOME; MICROARRAY ANALYSIS; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 4; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; UPREGULATION;

BIOLOGICAL TRANSPORT; CELL LINE; CHOLESTEROL; ENDOSOMES; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; LIPID METABOLISM; LIPIDS; LYSOSOMES; MICROARRAY ANALYSIS; MUCOLIPIDOSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VALIDATION STUDIES AS TOPIC;

EID: 40849137621     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.01.002     Document Type: Article

References (49)

1. Amir N., Zlotogora J., and Bach G. Mucolipidosis type IV: clinical spectrum and natural history. Pediatrics 79 (1987) 953-959
2. Berman E.R., Livni N., Shapira E., Merin S., and Levij I.S. Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis. J Pediatr 84 (1974) 519-526
3. Bach G. Mucolipidosis type IV. Mol. Genet. Metab. 73 (2001) 197-203
4. Bargal R., and Bach G. Phospholipids accumulation in mucolipidosis IV cultured fibroblasts. J. Inherit. Metab. Dis. 11 (1988) 144-150
5. Bach G., Ziegler M., Kohn G., and Cohen M.M. Mucopolysaccharide accumulation in cultured skin fibroblasts derived from patients with mucolipidosis IV. Am. J. Hum. Genet. 29 (1977) 610-618
6. Goldin E., Blanchette-Mackie E.J., Dwyer N.K., Pentchev P.G., and Brady R.O. Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent. Pediatr. Res. 37 (1995) 687-692
7. Bargal R., and Bach G. Mucolipidosis type IV: abnormal transport of lipids to lysosomes. J. Inherit. Metab. Dis. 20 (1997) 625-632
8. Zeigler M., and Bach G. Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis IV. Clin. Chim. Acta. 157 (1986) 183-189
9. Chen C.S., Bach G., and Pagano R.E. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6373-6378
10. Jansen S.M., Groener J.E., Bax W., and Poorthuis B.J. Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis. J. Inherit. Metab. Dis. 24 (2001) 577-586
11. Pagano R.E., Puri V., Dominguez M., and Marks D.L. Membrane traffic in sphingolipid storage diseases. Traffic (Copenhagen, Denmark) 1 (2000) 807-815
12. Bargal R., Avidan N., Ben-Asher E., Olender Z., Zeigler M., Frumkin A., Raas-Rothschild A., Glusman G., Lancet D., and Bach G. Identification of the gene causing mucolipidosis type IV. Nat. Genet. 26 (2000) 118-123
13. Bassi M.T., Manzoni M., Monti E., Pizzo M.T., Ballabio A., and Borsani G. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV. Am. J. Hum. Genet. 67 (2000) 1110-1120
14. Sun M., Goldin E., Stahl S., Falardeau J.L., Kennedy J.C., Acierno Jr. J.S., Bove C., Kaneski C.R., Nagle J., Bromley M.C., Colman M., Schiffmann R., and Slaugenhaupt S.A. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum. Mol. Genet. 9 (2000) 2471-2478
15. Vergarajauregui S., and Puertollano R. Two di-leucine motifs regulate trafficking of mucolipin-1 to lysosomes. Traffic (Copenhagen, Denmark) 7 (2006) 337-353
16. Pryor P.R., Reimann F., Gribble F.M., and Luzio J.P. Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic (Copenhagen, Denmark) 7 (2006) 1388-1398
17. Manzoni M., Monti E., Bresciani R., Bozzato A., Barlati S., Bassi M.T., and Borsani G. Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization. FEBS Lett. 567 (2004) 219-224
18. Kiselyov K., Chen J., Rbaibi Y., Oberdick D., Tjon-Kon-Sang S., Shcheynikov N., Muallem S., and Soyombo A. TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage. J. Biol. Chem. 280 (2005) 43218-43223
19. Soyombo A.A., Tjon-Kon-Sang S., Rbaibi Y., Bashllari E., Bisceglia J., Muallem S., and Kiselyov K. TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J. Biol. Chem. 281 (2006) 7294-7301
20. Hersh B.M., Hartwieg E., and Horvitz H.R. The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4355-4360
21. Fares H., and Greenwald I. Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nat. Genet. 28 (2001) 64-68
22. Treusch S., Knuth S., Slaugenhaupt S.A., Goldin E., Grant B.D., and Fares H. Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4483-4488
23. Smyth G.K. In: Gentleman R., Carey V., Huber W., Irizarry R., and Dudoit S. (Eds). Limma: Linear Models for Microarray Data (2005), Springer, New York 397-420
24. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., and Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5 (2004) R80
25. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., and Speed T.P. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30 (2002) e15
26. Benjamini Y., Drai D., Elmer G., Kafkafi N., and Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125 (2001) 279-284
27. Smyth G.K., Yang Y.H., and Speed T. Statistical issues in cDNA microarray data analysis. Methods Mol. Biol. 224 (2003) 111-136
28. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 (2003) R70
29. Draghici S., Khatri P., Bhavsar P., Shah A., Krawetz S.A., and Tainsky M.A. Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res. 31 (2003) 3775-3781
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
31. Lusa L., Cappelletti V., Gariboldi M., Ferrario C., De Cecco L., Reid J.F., Toffanin S., Gallus G., McShane L.M., Daidone M.G., and Pierotti M.A. Questioning the utility of pooling samples in microarray experiments with cell lines. Int. J. Biol. Markers 21 (2006) 67-73
32. Kendziorski C., Irizarry R.A., Chen K.S., Haag J.D., and Gould M.N. On the utility of pooling biological samples in microarray experiments. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4252-4257
33. Peng X., Wood C.L., Blalock E.M., Chen K.C., Landfield P.W., and Stromberg A.J. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 4 (2003) 26
34. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., Gaasterland T., Glenisson P., Holstege F.C., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., and Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29 (2001) 365-371
35. Woloszynek J.C., Roberts M., Coleman T., Vogler C., Sly W., Semenkovich C.F., and Sands M.S. Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII. Biochem. J. 379 (2004) 461-469
36. Cabrita M.A., Hobman T.C., Hogue D.L., King K.M., and Cass C.E. Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. Cancer Res. 59 (1999) 4890-4897
37. Pak Y., Glowacka W.K., Bruce M.C., Pham N., and Rotin D. Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination. J. Cell Biol. 175 (2006) 631-645
38. Duffield A., Kamsteeg E.J., Brown A.N., Pagel P., and Caplan M.J. The tetraspanin CD63 enhances the internalization of the H,K-ATPase beta-subunit. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15560-15565
39. Galperin E., Benjamin S., Rapaport D., Rotem-Yehudar R., Tolchinsky S., and Horowitz M. EHD3: a protein that resides in recycling tubular and vesicular membrane structures and interacts with EHD1. Traffic (Copenhagen, Denmark) 3 (2002) 575-589
40. Rotem-Yehudar R., Galperin E., and Horowitz M. Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29. J. Biol. Chem. 276 (2001) 33054-33060
41. Caplan S., Hartnell L.M., Aguilar R.C., Naslavsky N., and Bonifacino J.S. Human Vam6p promotes lysosome clustering and fusion in vivo. J. Cell Biol. 154 (2001) 109-122
42. Bach G., Chen C.S., and Pagano R.E. Elevated lysosomal pH in Mucolipidosis type IV cells. Clin. Chim. Acta 280 (1999) 173-179
43. Pillay C.S., Elliott E., and Dennison C. Endolysosomal proteolysis and its regulation. Biochem. J. 363 (2002) 417-429
44. Sun-Wada G.H., Wada Y., and Futai M. Diverse and essential roles of mammalian vacuolar-type proton pump ATPase: toward the physiological understanding of inside acidic compartments. Biochim. Biophys. Acta 1658 (2004) 106-114
45. 2+-dependent membrane trafficking in mucolipidosis IV. Biochem. Biophys. Res. Commun. 322 (2004) 1384-1391
46. Heeren J., Steinwaerder D.S., Schnieders F., Cichon G., Strauss M., and Beisiegel U. Nonphysiological overexpression of low-density lipoprotein receptors causes pathological intracellular lipid accumulation and the formation of cholesterol and cholesteryl ester crystals in vitro. J. Mol. Med. 77 (1999) 735-743
47. Cichon G., Willnow T., Herwig S., Uckert W., Loser P., Schmidt H.H., Benhidjeb T., Schlag P.M., Schnieders F., Niedzielska D., and Heeren J. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage. J. Gene. Med. 6 (2004) 166-175
48. Eberle D., Clement K., Meyre D., Sahbatou M., Vaxillaire M., Le Gall A., Ferre P., Basdevant A., Froguel P., and Foufelle F. SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 53 (2004) 2153-2157
49. Pury P.A., and Caceres M.O. Multifractal spectra of mean first-passage-time distributions in disordered chains. Phys. Rev. 67 (2003) 061106